Ian Clements, Ph.D., has served as chief financial officer since January 2020. Prior to this he served as senior vice president finance and communications and our principal financial and accounting officer since March 2019.
Prior to joining Mirum, Ian served as vice president of investor relations at Dermira, Inc. from May 2017 to March 2019. Ian served as vice president, investor relations and corporate communications at Tobira from July 2015 to December 2016. Prior to that, he was head of investor relations and corporate communications at Avanir Pharmaceuticals, from 2011 to June 2015. Ian has also held leadership positions at Sequenom, a genetic analysis and diagnostics company, and The Trout Group, where he managed west coast operations for life sciences investor relations.
Ian received a Ph.D. in chemistry from the University of Manchester, an MBA from the Open University in the United Kingdom and a B.Sc. in chemistry from Staffordshire University.